Endometrial cancer - reduce to the minimum. A new paradigm for adjuvant treatments? (Q35617503)

9 August 2017

1 reference

29 May 2020

1 reference

Endometrial cancer - reduce to the minimum. A new paradigm for adjuvant treatments? (English)

1 reference

9 August 2017

1 reference

1 reference

3

Claus Belka

1 reference

9 August 2017

Heike R Scheithauer

1

1 reference

9 August 2017

Diana S Schulz

series ordinal

2

1 reference

9 August 2017

language of work or name

1 reference

25 November 2011

5 references

9 August 2017

13 March 2019

14 March 2019

24 March 2019

3 April 2019

6 references

9 August 2017

13 March 2019

14 March 2019

24 March 2019

3 April 2019

29 May 2020

6

1 reference

9 August 2017

164

1 reference

Creative Commons Attribution 2.0 Generic

9 August 2017

4 references

13 March 2019

14 March 2019

24 March 2019

on focus list of Wikimedia project

3 April 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1748-717x-6-164

0 references

cites work

Prospective multi-center trial utilizing electronic brachytherapy for the treatment of endometrial cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239313

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239313

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239313

Stage II endometrial carcinoma: limiting post-operative radiotherapy to the vaginal vault in node-negative tumors

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239313

Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239313

The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239313

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239313

Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239313

The use of adjuvant radiation therapy by members of the Society of Gynecologic Oncologists

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239313

The Danish Endometrial Cancer Study (DEMCA).

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239313

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239313

Survival impact of lymph node dissection in endometrial adenocarcinoma: a surveillance, epidemiology, and end results analysis.

12 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-6-164

Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-6-164

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-6-164

Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-6-164

[Patients with early stages of endometrial cancer should be spared adjuvant radiotherapy. Danish Endometrial Cancer Group]

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3239313

The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer

25 September 2018

1 reference

12 December 2020

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

1 reference

12 December 2020

Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy

1 reference

12 December 2020

Potential benefit of lymphadenectomy for the treatment of node-negative locally advanced uterine cancers

1 reference

12 December 2020

Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer

1 reference

12 December 2020

GOG-99: ending the controversy regarding pelvic radiotherapy for endometrial carcinoma?

1 reference

12 December 2020

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

1 reference

12 December 2020

Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients

1 reference

12 December 2020

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

1 reference

12 December 2020

Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

1 reference

12 December 2020

The use of adjuvant radiation therapy in early endometrial cancer by members of the Society of Gynecologic Oncologists in 2005

1 reference

12 December 2020

ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid?

1 reference

12 December 2020

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

1 reference

12 December 2020

Radiotherapy: Intermediate-risk endometrial cancer--adjuvant treatment

1 reference

12 December 2020

Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial

1 reference

12 December 2020

Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma

1 reference

12 December 2020

Postoperative vaginal vault brachytherapy for node-negative Stage II (occult) endometrial carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1186/1748-717X-6-164

1 reference

Dimensions Publication ID

9 August 2017

0 references

1 reference

9 August 2017

1 reference